Literature DB >> 16939810

Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p.

Zhuo-Zhuang Lu1, Fang Ni, Ze-Bin Hu, Lan Wang, Hua Wang, Qun-Wei Zhang, Wen-Rong Huang, Chu-Tse Wu, Li-Sheng Wang.   

Abstract

OBJECTIVE: Adenoviral vectors (Ad) were widely used in gene therapy and study of gene function, but the commonly used serotype 5 adenovirus-based vectors (Ad5) could poorly transduce hematopoietic cells because of low expression of viral receptors on these cells. To overcome this limitation, we developed a retargeting adenovector with a chimeric fiber of Ad5 and Ad11p (Ad5F11p) and evaluated its gene transfer ability in hematopoietic cells.
MATERIALS AND METHODS: An Ad11p fiber pseudotyped Ad5 vector was generated by modifying the fiber gene of pAdEasy-1 backbone plasmid. Ad5F11p-GFP encoding enhanced green fluorescence protein (GFP) gene was transferred into human leukemic cell lines, primary leukemic cells, and CD34(+) hematopoietic cells. The gene transduction efficiency was determined by fluorescence-activated cell sorting assay.
RESULTS: More than 90% of U937 or K562 cells could be infected by Ad5F11p-GFP at a moderate multiplicity of infection (MOI). Ad5F11p-GFP is also significantly more effective than control Ad5-GFP in infection of primary myeloid leukemic cells. At 200 MOI, GFP-positive percentages of Ad5F11p-GFP transduced myeloid leukemic cells range from 10.58% to 92.63% with a median of 28.65%. Ad5F11p-GFP could transduce about 50% human hematopoietic stem/progenitor (CD34(+)) cells, while Ad5-GFP could transduce <15% at 200 MOI. CD46 was reported to be the receptor of Ad11p. Our data suggest that CD46 participates in the process of Ad5F11p-GFP infection but is not the unique molecule determining its gene transfer efficiency of host cells.
CONCLUSION: We established a retargeting adenovector system, which could infect hematopoietic cells effectively and would benefit research work on Ad tropism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939810     DOI: 10.1016/j.exphem.2006.05.005

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  12 in total

1.  Assessment of the green florescence protein labeling method for tracking implanted mesenchymal stem cells.

Authors:  Yinghua Guo; Longxiang Su; Junlou Wu; Dong Zhang; Xiaojun Zhang; Guizhi Zhang; Tianzhi Li; Junfeng Wang; Changting Liu
Journal:  Cytotechnology       Date:  2012-02-29       Impact factor: 2.058

Review 2.  In Vivo Hematopoietic Stem Cell Transduction.

Authors:  Maximilian Richter; Daniel Stone; Carol Miao; Olivier Humbert; Hans-Peter Kiem; Thalia Papayannopoulou; André Lieber
Journal:  Hematol Oncol Clin North Am       Date:  2017-10       Impact factor: 3.722

Review 3.  Development of gene therapy for inner ear disease: Using bilateral vestibular hypofunction as a vehicle for translational research.

Authors:  Hinrich Staecker; Mark Praetorius; Douglas E Brough
Journal:  Hear Res       Date:  2011-01-18       Impact factor: 3.208

4.  Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers.

Authors:  Youguang Zhao; Ying Li; Qingtang Wang; Liang Wang; Hang Yang; Mingli Li
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

5.  Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.

Authors:  Dawn A Maier; Andrea L Brennan; Shuguang Jiang; Gwendolyn K Binder-Scholl; Gary Lee; Gabriela Plesa; Zhaohui Zheng; Julio Cotte; Carmine Carpenito; Travis Wood; S Kaye Spratt; Dale Ando; Philip Gregory; Michael C Holmes; Elena E Perez; James L Riley; Richard G Carroll; Carl H June; Bruce L Levine
Journal:  Hum Gene Ther       Date:  2013-03-06       Impact factor: 5.695

6.  The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.

Authors:  Yinghua Guo; Longxiang Su; Yinghui Li; Na Guo; Lixin Xie; Dong Zhang; Xiaojun Zhang; Hongxia Li; Guizhi Zhang; Yajuan Wang; Changting Liu
Journal:  Heart Vessels       Date:  2013-08-10       Impact factor: 2.037

7.  Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation.

Authors:  Kamola Saydaminova; Xun Ye; Hongjie Wang; Maximilian Richter; Martin Ho; HongZhuan Chen; Ning Xu; Jin-Soo Kim; Eirini Papapetrou; Michael C Holmes; Philip D Gregory; Donna Palmer; Philip Ng; Anja Ehrhardt; André Lieber
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-14       Impact factor: 6.698

8.  A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.

Authors:  Wenjuan Cao; Junqiang Tian; Chong Li; Yanjun Gao; Xingchen Liu; Jianzhong Lu; Yuhan Wang; Zhiping Wang; Robert S Svatek; Ronald Rodriguez
Journal:  Virol J       Date:  2017-08-08       Impact factor: 4.099

9.  Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5.

Authors:  Yun Lv; Feng-Jun Xiao; Yi Wang; Xiao-Hui Zou; Hua Wang; Hai-Yan Wang; Li-Sheng Wang; Zhuo-Zhuang Lu
Journal:  BMC Biotechnol       Date:  2019-04-24       Impact factor: 2.563

10.  Establishment of a Parvovirus B19 NS1-Expressing Recombinant Adenoviral Vector for Killing Megakaryocytic Leukemia Cells.

Authors:  Peng Xu; Xiaomei Wang; Yi Li; Jianming Qiu
Journal:  Viruses       Date:  2019-09-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.